Dräger Fluorescent Lamp for Photo-Therapy 4000: Effective Solution for Bilirubin Reduction in Infants
The Dräger Fluorescent Lamp for Photo-Therapy 4000 represents a significant advancement in the treatment of hyperbilirubinemia in infants, offering an innovative and highly effective solution to substantially reduce elevated levels of serum bilirubin. The ingenious use of optimized blue and white lights makes this lamp an essential instrument in the management of neonatal jaundice.
Dräger's Photo-Therapy 4000 has gained its reputation for exceptional reliability and minimal operating costs, making it a preferred piece of equipment for treating high concentrations of bilirubin in newborns. Its ergonomic design and ease of use make it a recommended choice for neonatal units, pediatric services, and nurseries, where its effectiveness in phototherapy is leveraged.
The high-intensity light emission (irradiance) of the PT 4000 is meticulously calibrated to focus on the most effective wavelengths, providing extensive coverage over the infant's bed surface. The blue part of the spectrum, characterized by a peak absorption at 460 nm, proves particularly effective for bilirubin decomposition. Dräger's "blue" fluorescent lamps emit rays precisely in this range, making them ideal for this specific treatment.
Notable features of the PT 4000 include its lightweight, silent operation, and compact dimensions, making it an ideal device for nurseries dedicated to healthy babies, neonatal intensive care units (NICU), and pediatric services. Its innovative design ensures maximum light diffusion where the blue part of the spectrum is most effective in decomposing bilirubin, with a peak absorption at 460 nm.
The included fluorescent tubes are specially designed for use with the Photo-Therapy 4000. Users can choose between white or blue fluorescent lamps, providing flexibility tailored to the individual needs of the patient. This variety allows for in-depth customization of the treatment based on the specific characteristics of the infant, offering a more personalized and effective approach to phototherapy.
It is important to note that the sale of the Photo-Therapy 4000 as a complete unit has been discontinued. However, the fluorescent lamps are still available as replacement parts or accessories, ensuring continuity of care for those who already own this unit.
The Dräger Fluorescent Lamp for Photo-Therapy 4000 stands out as a preferred choice for the treatment of hyperbilirubinemia in infants.
Its proven effectiveness, exceptional reliability, and practical design make it an indispensable tool in the field of pediatrics, providing a safe and optimal method to reduce serum bilirubin levels and ensure the well-being of infants.
Whether used in a neonatal unit, pediatric service, or nursery, the Dräger Fluorescent Lamp for Photo-Therapy 4000 remains at the forefront of innovation in pediatric phototherapy.
